The first synthesis of QS-21A, a medicinally important molecule that helps the body battle disease, has been achieved by chemists at the University of Illinois at Urbana-Champaign.In clinical tri
Scientists at the University of Michigan Medical School have discovered a gene called NPHP5 and found mutations in this gene that cause a rare genetic disease called Senior-Loken syndrome. Children
If there were no bench for second-string players on a football team, who would substitute for tired or injured team members? A team of Weizmann Institute scientists has found that, if the team were
Reactive oxygen species (ROS), or 'oxygen radicals', have been identified as major contributors to signs of premature aging, increased cancer prevalence linked to inflammation-associated syndromes and a variety of human diseases. Now scientists
A biologist at Washington University in St. Louis is giving the VIP treatment to laboratory mice in hopes of unraveling more clues about our biological clock. VIP is not "very important person,"
By analyzing the relationship between the geographic location of current human populations in relation to East Africa and the genetic variability within these populations, researchers have found new evidence for an African origin of modern humans.
The UK will vote against the declaration on human cloning at the
A team of Japanese scientists at Osaka University led by Dr Masaru Okabe have discovered a protein essential for human sperm to fuse to an egg. The findings could well lead to new methods of treatin
Anthropologists have constructed the world's first complete articulated Neanderthal skeleton to expand public and scientific understanding of the group, as well as of the differences between Neanderthals and modern humans. Their research will b
An international team led by researchers at the Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology in Liepzig, Germany and W
Date: Monday, 20-Nov-2006
Quantum dots are rapidly becoming biomedical researchers' tool of choice for adding a fluorescent label to a wide variety of biomolecules.Now, thanks to work from a multi-institutional team of investigators, researchers may have a simple, generic method for attaching quantum dots to proteins in a highly controlled manner. Amy Blum, Ph.D., of the Naval Research Laboratory, led this team, which published its results in the journal Nanotechnology.
The investigators took advantage of the fact that quantum dots bind strongly to short peptides containing the amino acid histidine, and that such histidine-containing peptides bind strongly to regions of a protein that contain the amino acid lysine. The researchers start by first mixing a commercially available histidine-containing peptide with the protein they want to label - in this paper, the researchers used an antibody and a virus particle as their target proteins. They then add water-soluble cadmium selenide/zinc sulfide quantum dots to the modified protein, let the mixture sit at room temperature for two days, and then remove the unreacted quantum dots using either gel electrophoresis for small batches or size exclusion chromatography for larger batches.
Experiments with the virus particle showed that quantum dot labeling was uniform and controlled using this method. The researchers observed that this method prevented the formation of quantum dot-protein aggregates, a common occurrence using other labeling techniques. The researchers note that while other investigators obtained similar results using proteins that had been engineered to have histidines available to bind quantum dots, this new method uses off-the-shelf chemicals rather than laboriously engineered proteins to achieve the same end.
Another important issue that the investigators addressed was the need to ensure that the labeling process did not interfere with the protein's function. To determine if the new method did indeed produce functional, labeled proteins, the researchers tested the labeled antibody to see if it still bound to its target with the same avidity as unlabeled antibody. This experiment showed that antibody binding ability was unchanged after quantum dot labeling.
This work is detailed in a paper titled, "Templated self-assembly of quantum dots from aqueous solution using protein scaffolds." Investigators from Geo-Centers, Inc., George Mason University, and The Scripps Research Institute also participated in this study. An abstract of this paper is available at the journal's website. View abstract.
http://nano.cancer.gov